Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 24.23M $3.79B June 30, 2014
FMR 20.68M $3.15B March 31, 2014
T. Rowe Price Associates 17.30M $2.70B June 30, 2014
Vanguard 10.09M $1.58B June 30, 2014
Jennison Associates 8.15M $1.27B June 30, 2014
STATE STREET CORPORATION 7.91M $1.24B June 30, 2014
JPMORGAN CHASE & CO 7.06M $1.10B June 30, 2014
Sands Capital Management 5.28M $824.97M June 30, 2014
Wells Fargo & Company 5.23M $817.69M June 30, 2014
BlackRock Institutional Trust Company, N.A. 5.08M $794.28M June 30, 2014
Inves 4.15M $631.87M March 31, 2014
BlackRock Fund Advisors 4.13M $644.60M June 30, 2014
Columbia Wanger Asset Management 3.71M $344.78M March 31, 2012
VIKING GLOBAL INVESTORS 2.88M $382.30M Dec. 31, 2013
WINSLOW CAPITAL MANAGEMENT INC /MN 2.87M $448.97M June 30, 2014
Ameriprise Financial 2.78M $435.10M June 30, 2014
American Century Companies 2.77M $432.26M June 30, 2014
NORTHERN TRUST 2.75M $419.07M March 31, 2014
Artisan Partners Limited Partnership 2.32M $352.40M March 31, 2014